Validation of a Single Rest-Stress Imaging Protocol for Myocardial Perfusion Imaging
Status: | Recruiting |
---|---|
Conditions: | Angina, Peripheral Vascular Disease, Peripheral Vascular Disease, Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 30 - 75 |
Updated: | 3/8/2019 |
Start Date: | September 21, 2017 |
End Date: | December 30, 2019 |
Contact: | Julia Scotton, BS |
Email: | jscotton@partners.org |
Phone: | 617-643-1967 |
We propose a single-scan two-injection myocardial perfusion imaging protocol using ammonia.
Subjects will undergo single-scan two-injection imaging as well as regular stress single-scan
single-injection protocol and the myocardial blood flow of both techniques will be compared.
Subjects will undergo single-scan two-injection imaging as well as regular stress single-scan
single-injection protocol and the myocardial blood flow of both techniques will be compared.
Healthy Volunteers:
Inclusion Criteria:
- Subjects must be ≥30 and ≤75 years of age;
- Subjects must provide informed consent prior to study procedures;
Exclusion Criteria:
- History of CAD, including:
- Prior abnormal myocardial perfusion study
- History of MI
- History of angina
- Coronary artery obstruction >50% on CTA and/or angiography
- Left ventricular ejection fraction <50%
- Any relative or absolute contraindication to adenosine stress, including:
- 2nd or 3rd degree heart block
- Bradycardia (HR<50 bpm)
- Recent acute coronary syndrome (ACS)
- Unstable angina
- Severe heart failure (left ventricular ejection fraction <15%)
- Ventricular arrhythmia
- Severe asthma and/or chronic obstructive pulmonary disease (COPD)
- Baseline hypotension defined as systolic blood pressure < 90 mmHg
- Caffeine intake within 24 hours prior to imaging
- Current use of theophylline, dipyridamole, or carbamazepine
- Allergy or intolerance to adenosine
- Positive serum and/or urine pregnancy test, or lactating, or possibility of pregnancy
cannot be ruled out prior to dosing;
Subjects with CAD:
Inclusion criteria
- Subjects must be ≥30 and ≤75 years of age;
- Subjects must provide informed consent prior to study procedures;
- Abnormal myocardial perfusion study within the past 12 months
Exclusion criteria
- Revascularization (percutaneous coronary intervention and/or coronary artery bypass)
following last myocardial perfusion study
- Acute coronary syndrome within 30 days
- Left ventricular ejection fraction <50%
- Any relative or absolute contraindication to adenosine stress, including:
- 2nd or 3rd degree heart block
- Bradycardia (HR<50 bpm)
- Recent acute coronary syndrome (ACS)
- Unstable angina
- Severe heart failure (left ventricular ejection fraction <15%)
- Ventricular arrhythmia
- Severe asthma and/or chronic obstructive pulmonary disease (COPD)
- Baseline hypotension defined as systolic blood pressure < 90 mmHg
- Caffeine intake within 24 hours prior to imaging
- Current use of theophylline, dipyridamole, or carbamazepine
- Allergy or intolerance to adenosine
- Any clinically significant acute or unstable physical or psychological disease, judged
by the investigators, to be incompatible with the study;
- Radiation exposure exceeds current Radiology Department guidelines (i.e. 50 mSv in the
prior 12 months);
- Female participants only: Positive serum and/or urine pregnancy test, or lactating, or
possibility of pregnancy cannot be ruled out prior to dosing;
- Inability to provide written informed consent;
We found this trial at
1
site
Click here to add this to my saved trials